Coexistence of cardio-renal-metabolic (CRM) disorders may increase the risk of mortality in patients. Here Drs. Peter McCullough and Rachel Pessah-Pollack discuss the effects of coexisting CRM disorders on cardiovascular mortality and overall life expectancy, as well as how a collaborative care approach could improve patient outcomes.
This is part 3 of a 3-part podcast series. Please listen to podcasts 1 and 2 before listening to this podcast.
Copyright © 2021 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.